HEPATITIS
Diagnosis,
Diagnostics, Immunodiagnosis & Immunodiagnostics:
Alberti
A, Noventa F, Benvegnu L, Boccato S, Gatta A. Prevalence of liver disease in
a population of asymptomatic persons with hepatitis C virus infection.Ann
Intern Med. 2002 Dec 17;137(12):961-4.
Apolinario
A, Majano PL, Alvarez-Perez E, Saez A, Lozano C, Vargas J, Garcia Monzon C.
Increased expression of T cell chemokines and their receptors in chronic
hepatitis C: relationship with the histological activity of liver disease.
Am J Gastroenterol. 2002 Nov;97(11):2861-70.
Barash
J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y. Human parvovirus B19 infection in children: uncommon clinical
presentations. Isr Med Assoc J. 2002 Oct;4(10):763-5.
Bergamini
A, Cepparulo M, Bolacchi F, Araco A, Tisone G, Ombres D, Rocchi G, Angelico
M. Ribavirin increases mitogen- and antigen-induced expression of CD40L on
CD4+ T cells in vivo.Clin Exp Immunol. 2002 Nov;130(2):293-9.
Boyle
BA. Recent research in HIV infection, part 2. AIDS Read. 2002
Dec;12(12):524-6, 539.
Chang
YC, Ho CL, Chen HH, Chang TT, Lai WW, Dai YC, Lee WY, Chow NH. Molecular
diagnosis of primary liver cancer by microsatellite DNA analysis in the
serum.Br J Cancer. 2002 Dec 2;87(12):1449-53.
Clark
CH, Mahoney JS, Clark DJ, Eriksen LR. Screening for depression in a
hepatitis C population: the reliability and validity of the Center for
Epidemiologic Studies Depression Scale (CES-D).J Adv Nurs. 2002
Nov;40(3):361-9.
Davis
GL. Monitoring of viral levels during therapy of hepatitis C. Hepatology.
2002 Nov;36(5 Suppl 1):S145-51.
Di
Martino V, Thevenot T, Colin JF, Boyer N, Martinot M, Degos F, Coulaud JP,
Vilde JL, Vachon F, Degott C, Valla D, Marcellin P. Influence of HIV infection on the response to interferon
therapy and the long-term outcome of chronic hepatitis B.Gastroenterology.
2002 Dec;123(6):1812-22.
Diment
J, Calmann M. Alternatives to nucleic acid testing in the blood transfusion
service.Lancet. 2002 Nov 9;360(9344):1518-9; author reply 1519-20.
Edlin
BR. Prevention and treatment of hepatitis C in injection drug users.
Hepatology. 2002 Nov;36(5 Suppl 1):S210-9.
Fleming
J. Current treatments for hepatitis. J Infus Nurs. 2002
Nov-Dec;25(6):379-82.
Fontana
RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C.
Hepatology. 2002 Nov;36(5 Suppl 1):S57-64.
Forns
X, Ampurdanes S, Llovet JM,Aponte J, Quinto L, Martinez-Bauer E, Bruguera M,
Sanchez-Tapias JM, Rodes J. Identification of chronic hepatitis C patients
without hepatic fibrosis by a simple predictive model. Hepatology. 2002
Oct;36(4 Pt 1):986-92.
Hagan
H, Thiede H, McGough JP, Alexander ER. Hepatitis B vaccination among
research participants, Seattle, Washington. Am J Public Health. 2002
Nov;92(11):1756.
Hassan
MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ.
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral
hepatitis and diabetes mellitus. Hepatology. 2002 Nov;36(5):1206-13.
Izumi
Y, Kaneko A, Oku K, Kimura M, Tanaka S, Tada H, Tatsumi K, Takano T, Hidaka
Y, Amino N. Development of liver dysfunction after delivery is possibly due
to postpartum autoimmune hepatitis. A report of three cases. J Intern Med.
2002 Oct;252(4):361-7.
Kamal
SM, Fehr J, Roesler B, Peters T, Rasenack JW. Peginterferon alone or with
ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with
chronic hepatitis C. Gastroenterology. 2002 Oct;123(4):1070-83.
Kanno
A, Kazuyama Y. Immunoglobulin G antibody avidity assay for serodiagnosis of
hepatitis C virus infection. J Med Virol. 2002 Oct;68(2):229-33.
Kawai
S, Yokosuka O, Imazeki F, Saisho H, Mizuno C. Evaluation of the clinical
usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with
AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level. J Med Virol.
2002 Nov;68(3):343-51.
Kobayashi
T, Sugawara Y, Shi YZ, Makuuchi M. Telomerase expression and p53 status in
hepatocellular carcinoma. Am J Gastroenterol. 2002 Dec;97(12):3166-71.
Kuehne
FC, Bethe U, Freedberg K, Goldie SJ. Treatment for hepatitis C virus in
human immunodeficiency virus-infected patients: clinical benefits and
cost-effectiveness. Arch Intern Med. 2002 Dec 9-23;162(22):2545-56.
Leifeld
L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, Spengler U.
Imbalanced intrahepatic expression of interleukin 12, interferon
gamma, and interleukin 10 in fulminant hepatitis B. Hepatology. 2002
Oct;36(4 Pt 1):1001-8.
Marcellin
P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C.
Hepatology. 2002 Nov;36(5 Suppl 1):S47-56.
Mazziotti
G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF,
Cioffi M, Gaeta GB, Caporaso N, Carella C.
Serum insulin-like growth factor I evaluation as a useful tool for
predicting the risk of developing hepatocellular carcinoma in patients with
hepatitis C virus-related cirrhosis: a prospective study. Cancer. 2002 Dec
15;95(12):2539-45.
McCulloch
M, Broffman M, Gao J, Colford JM Jr. Chinese herbal medicine and interferon
in the treatment of chronic hepatitis B: a meta-analysis of randomized,
controlled trials. Am J Public Health. 2002 Oct;92(10):1619-28.
Menon
Y, Singh R, Cuchacovich R, Espinoza LR. Pulmonary involvement in hepatitis
B-related polyarteritis nodosa. Chest. 2002 Oct;122(4):1497-8.
Nikolova
M, Liubomirova M, Iliev A, Krasteva R, Andreev E, Radenkova J, Minkova V,
Djerassi R, Kiperova B, Vlahov ID. Clinical
significance of antinuclear antibodies, anti-neutrophil cytoplasmic
antibodies and anticardiolipin antibodies in heroin abusers. Isr Med Assoc
J. 2002 Nov;4(11 Suppl):908-10.
Ostapowicz
G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM,
Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM.
Results of a prospective study of acute liver failure at 17 tertiary care
centers in the United States.Ann Intern Med. 2002 Dec 17;137(12):947-54.
Pawlotsky
JM. Use and interpretation of virological tests for hepatitis C. Hepatology.
2002 Nov;36(5 Suppl 1):S65-73.
Pol
S, Lebray P.N-acetylcysteine for paracetamol poisoning: effect on
prothrombin. Lancet. 2002 Oct 12;360(9340):1115.
Pradat
P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, Badalamenti S,
Trepo C. Predictive value of
ALT levels for histologic findings in chronic hepatitis C: a European
collaborative study. Hepatology. 2002 Oct;36(4 Pt 1):973-7.
Prokurat
A, Kluge P, Chrupek M, Kosciesza A, Rajszys P. Hemangioma of the liver in
children: proliferating vascular tumor or congenital vascular malformation?
Med Pediatr Oncol. 2002 Nov;39(5):524-9.
Renou
C, Pol S, Halfon P, Caillat-Zucman S. Controversies about the histological
features of chronic HCV patients with persistently normal alanine
transaminase levels: what can be done about the present definition?
Gastroenterology. 2002 Nov;123(5):1748-9
Requena-Silla
Y, Rosenfield CG, Miller LC. Antiphospholipid
antibodies and Down syndrome: a case series. J Pediatr Hematol Oncol. 2002
Oct;24(7):575-8.
Pathogenesis :
Agnello
V, Mecucci C, Casato M. Regression of splenic lymphoma after treatment of
hepatitis C virus infection.N Engl J Med. 2002 Dec 26;347(26):2168-70
Buendia
MA. Genetic alterations in hepatoblastoma and hepatocellular carcinoma:
common and distinctive aspects. Med Pediatr Oncol. 2002 Nov;39(5):530-5.
Cainelli
F, Vento S. Sequelae and
serologic outcome in persons with hepatitis B virus infection. Ann Intern
Med. 2002 Oct 1;137(7):619
Cheney
IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C, Hong Z, Lau JY, Tam RC.
Comparative analysis of anti-hepatitis C virus activity and gene expression
mediated by alpha, beta, and gamma interferons.J Virol. 2002
Nov;76(21):11148-54.
Cooper
CL, Cameron DW. Review of the effect of highly active antiretroviral therapy
on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and
HCV coinfection. Clin Infect Dis. 2002 Oct 1;35(7):873-9.
Diamond
C, Lee JH. Use of antiviral therapy in patients with hepatitis C. Ann Intern
Med. 2002 Dec 17;137(12):1012.
Engels
EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ. Prevalence of
hepatitis C virus infection and risk for hepatocellular carcinoma and
non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr. 2002 Dec
15;31(5):536-41.
Guida
M, D'Elia G, Benvestito S, Casamassima A, Micelli G, Quaranta M, Moschetta
R, De Lena M, Lorusso V. Hepatitis C virus infection in patients with B-cell
lymphoproliferative disorders.Leukemia. 2002 Oct;16(10):2162-3.
Halkic
N, Bally F, Gillet M. Organ transplantation in HIV-infected patients. N Engl
J Med. 2002 Nov 28;347(22):1801-3
Hofer
H, Bankl HC, Wrba F, Steindl-Munda P, Peck-Radosavljevic M, Osterreicher C,
Mueller C, Gangl A, Ferenci P. Hepatocellular
fat accumulation and low serum cholesterol in patients infected with HCV-3a.
Am J Gastroenterol. 2002 Nov;97(11):2880-5.
Huang
JW, Yen CJ, Pai MF, Wu KD, Tsai TJ, Hsieh BS. Association between serum
aspartate transaminase and homocysteine levels in hemodialysis patients.Am J
Kidney Dis. 2002 Dec;40(6):1195-201.
Jacobs
RJ, Meyerhoff AS, Koff RS. Re: Arguedas et al.--Hepatitis A prevention
analysis.Am J Gastroenterol. 2002 Nov;97(11):2924-5
Johnson
B.Hepatitis C: be positively aware of the risk of transmission and
treatment. Posit Aware. 2002 Nov-Dec;13(6):29-31.
Labonte
P, Axelrod V, Agarwal A, Aulabaugh A, Amin A, Mak P. Modulation of hepatitis
C virus RNA-dependent RNA polymerase activity by structure-based
site-directed mutagenesis. J Biol Chem. 2002 Oct 11;277(41):38838-46.
Loustaud-Ratti
V, Liozon E, Karaaslan H, Alain S, Paraf F, Le Meur Y, Denis F, Vidal
E.Interferon alpha and ribavirin for membranoproliferative
glomerulonephritis and hepatitis C infection. Am J Med. 2002 Oct
15;113(6):516-9.
Okuda
K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1:
epidemiology and etiology. J Gastroenterol Hepatol. 2002 Oct;17(10):1049-55.
Osawa
Y, Nagaki M, Banno Y, Brenner DA, Asano T, Nozawa Y, Moriwaki H, Nakashima
S. Tumor necrosis factor alpha-induced interleukin-8 production via NF-kappaB
and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in
human hepatocytes. Infect Immun. 2002 Nov;70(11):6294-301.
Pande
H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis: report of five
cases.Dig Dis Sci. 2002 Dec;47(12):2664-8.
Qian
GS, Kuang SY, He X, Groopman JD, Jackson PE. Sensitivity of electrospray
ionization mass spectrometry detection of codon 249 mutations in the p53
gene compared with RFLP.Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt
1):1126-9.
Razonable
RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ,
Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV. The pathogenesis of
hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002
Oct 15;35(8):974-81.
Ressel
GW.CDC releases 2002 guidelines for treating STDs: Part II. Human
papillomavirus and hepatitis. Am Fam Physician. 2002 Nov 15;66(10):1996,
1999.
Rossi
A, Renzetti D, D'Albenzio L, Gianfelice D, Kalyvoka A, Rinaldi O. Case of
mania induced by withdrawal of interferon-alpha in a patient affected by
bipolar disorder. Psychiatry Clin Neurosci. 2002 Dec;56(6):647-8.
Sarrazin
C, Herrmann E, Bruch K, Zeuzem S. Hepatitis C virus nonstructural 5A protein
and interferon resistance: a new model for testing the reliability of
mutational analyses. J Virol. 2002 Nov;76(21):11079-90.
Sharma
SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK. Evaluation of clinical and
immunogenetic risk factors for the development of hepatotoxicity during
antituberculosis treatment. Am J Respir Crit Care Med. 2002 Oct
1;166(7):916-9.
Somjee
S, Pai S, Parikh P, Banavali S, Kelkar R, Advani S. Passive active prophylaxis against Hepatitis B in children
with acute lymphoblastic leukemia. Leuk Res. 2002 Nov;26(11):989-92.
Stancu
M, Jones D, Vega F, Medeiros LJ. Peripheral
T-cell lymphoma arising in the liver. Am J Clin Pathol. 2002
Oct;118(4):574-81.
Terui
Y, Saito T, Watanabe H, Togashi H, Kawata S, Kamada Y, Sakuta S.
Effect of angiotensin receptor antagonist on liver fibrosis in early
stages of chronic hepatitis C. Hepatology. 2002 Oct;36(4 Pt 1):1022.
Thio
CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL.
HIV-1, hepatitis B virus, and risk of liver-related mortality in the
Multicenter Cohort Study (MACS). Lancet. 2002 Dec 14;360(9349):1921-6.
Thomas
DL. Hepatitis C and human immunodeficiency virus infection. Hepatology. 2002
Nov;36(5 Suppl 1):S201-9.
Tiffen
L, Sheridan S. Improving take-up of hepatitis C services. Nurs Times. 2002
Oct 22-28;98(43):30-2.
Welch
KJ, Morse A. Improving screening and vaccination for hepatitis B in patients
coinfected with HIV and hepatitis C. Am J Gastroenterol. 2002
Nov;97(11):2928-9.
Whiting
PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated
with acute hepatitis. Med J Aust. 2002 Oct 21;177(8):440-3.
Wright
TL. Treatment of patients with hepatitis C and cirrhosis. Hepatology. 2002
Nov;36(5 Suppl 1):S185-94.
Yao
N, Hong Z, Lau JY. Application of structural biology tools in the study of
viral hepatitis and the design of antiviral therapy. Gastroenterology. 2002
Oct;123(4):1350-63.
Young
KC, Lin PW, Hsiao WC, Chang TT, Chang YC, Wu HL. Variation of hepatitis C
virus load, hypervariable region 1 quasispecies and CD81 hepatocyte
expression in hepatocellular carcinoma and adjacent non-cancerous liver. J
Med Virol. 2002 Oct;68(2):188-96.
Youssef
WI, Tavill AS. Connective tissue diseases and the liver. J Clin
Gastroenterol. 2002 Oct;35(4):345-9.
Zhu
H, Wang SY, Zhang JY, Lian QZ, Peng XX.
Analysis of complement-bound HCV complexes using a novel immuno-capture
RT-PCR method. Scand J Immunol. 2002 Nov;56(5):538-42.
Vaccines :
Lohr HF, Pingel S, Bocher WO, Bernhard H, Herzog-Hauff S, Rose-John S, Galle PR. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12. Clin Exp Immunol. 2002 Oct;130(1):107-14.
Back |